GEIST:UPC Searchengine

ORD_39595/2024

Abbott Diabetes Care Inc.

Datum
2024-07-03
Kammer
Düsseldorf (DE) Local Division
Verfahrensart
Generic application
Sprache
EN

Metadaten

Fall-IDORD_39595-2024-cf731bd9284a
Aktenzeichen
RegisterzeichenORD_39595/2024
EntscheidungsreferenzORD_39595/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 7

1 Düsseldorf Local Division UPC_CFI_133/2024 Decision of the Court of First Instance of the Unified Patent Court issued on 3 July 2024 concerning EP 2 393 417 B1 APPLICANT: Abbott Diabetes Care Inc. of 1360 South Loop Road, Alameda, CA 94502, United States of America, Represented by: Attorney at Law Roland Küppers, Attorney at Law Dr. Alexander Rubusch, Benrather Str. 15, 40213 Düsseldorf, Germany, Electronic address for service: r.kueppers@taylorwessing.com DEFENDANTS: 1. SIBIO TECHNOLOGY LIMITED of 6/F., Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong, Special Administrative Region of the People's Republic of China, 2. UMEDWINGS NETHERLANDS B.V. of Treubstraat, 1, 2288EG, Rijswijk, The Netherlands, Represented by: Attorney at Law Thomas Gniadek, Thierschplatz 6, 80538 Munich, Germ ...